Erratum: Synthesis and biologic activities of some novel heterocyclic chalcone derivatives (Med Chem Res DOI 10.1007/s00044-012-0401-7);Synthesis and biologic activities of some novel heterocyclic chalcone derivatives

Medicinal Chemistry Research

Volumn 22, Issue 8, 2013, Pages 3969-3983

  Sharma, Punita ^a   Kumar, Suresh ^a   Ali, Furquan ^a   Anthal, Sumati ^b   Gupta, Vivek K ^b   Khan, Inshad A ^a   Singh, Surjeet ^a   Sangwan, Payare L ^a   Suri, Krishan A ^a   Gupta, Bishan D ^a   Gupta, Devinder K ^a   Dutt, Prabhu ^a   Vishwakarma, Ram A ^a   Satti, Naresh K ^a  

^a CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

^b UNIVERSITY OF JAMMU   (India)

Author keywords

(E) 3 (substitutedphenyl) 1 hetrylprop 2 en 1 ones; Chalcone; Docking study; NorA efflux pump inhibitors; Staphylococcus aureus

Indexed keywords

3 (2 BROMOPHENYL) 1 (1H PYRROL 2 YL)PROP 2 EN 1 ONE; 3 (2 BROMOPHENYL)1 (FURAN 2 YL)PROP 2 EN 1 ONE; 3 (2 CHLORO 5 NITROPHENYL) 1 (1H PYRROL 2 YL)PROP 2 EN 1 ONE; 3 (2 CHLOROPHENYL) 1 (1H PYRROL 2 YL)PROP 2 EN 1 ONE; 3 (2 CHLOROPHENYL) 1 (FURAN 2 YL)PROP 2 EN 1 ONE; 3 (2,3 DICHLOROPHENYL) 1 (1H PYRROL 2 YL)PROP 2 EN 1 ONE; 3 (2,3 DIMETHOXYPHENYL) 1 (1H PYRROL 2 YL)PROP 2 EN 1 ONE; 3 (2,4 DIMETHOXYPHENYL) 1 (1H PYRROL 2 YL)PROP 2 EN 1 ONE; 3 (2,6 DICHLOROPHENYL) 1 (1H PYRROL 2 YL)PROP 2 EN 1 ONE; 3 (2,6 DIMETHOXYPHENYL)1 (1H PYRROL 2 YL)PROP 2 EN 1 ONE; 3 (3 METHOXYPHENYL) 1 (1H PYRROL 2 YL)PROP 2 EN 1 ONE; 3 (3 NITROPHENYL) 1 (1H PYRROL 2 YL)PROP 2 EN 1 ONE; 3 (3 NITROPHENYL) 1 (FURAN 2 YL)PROP 2 EN 1 ONE; 3 (3,4 DIMETHOXYPHENYL) 1 (1H PYRROL 2 YL)PROP 2 EN 1 ONE; 3 (3,4 DIMETHOXYPHENYL) 1 (FURAN 2 YL)PROP 2 EN 1 ONE; 3 (4 BROMOPHENYL) 1 (1H PYRROL 2 YL)PROP 2 EN 1 ONE; 3 (4 CHLOROPHENYL) 1 (1H PYRROL 2 YL)PROP 2 EN 1 ONE; 3 (4 CHLOROPHENYL) 1 (FURAN 2 YL)PROP 2 EN 1 ONE; 3 (4 DIMETHYLAMINOPHENYL) 1 (1H PYRROL 2 YL)PROP 2 EN 1 ONE; 3 (4 DIMETHYLAMINOPHENYL) 1 (FURAN 2 YL)PROP 2 EN 1 ONE; 3 (4 FLUOROPHENYL) 1 (1H PYRROL 2 YL)PROP 2 EN 1 ONE; 3 (4 NITROPHENYL) 1 (1H PYRROL 2 YL)PROP 2 EN 1 ONE; 3 (4-FLUOROPHENYL) 1 (FURAN 2 YL)PROP 2 EN 1 ONE; 3 (42,4 DICHLOROPHENYL) 1 (1H PYRROL 2 YL)PROP 2 EN 1 ONE; 3 (PHENYL) 1 (FURAN 2 YL)PROP 2 EN 1 ONE; 3 PHENYL 1 (1H PYRROL 2 YL)PROP 2 EN 1 ONE; CHALCONE DERIVATIVE; CIPROFLOXACIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CANCER CELL CULTURE; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; HUMAN; MEDICAL LITERATURE; MOLECULAR DOCKING; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

EID: 84879500073     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-012-0444-9     Document Type: Erratum

References (39)

1. Achanta G, Modzelewska A, Feng L, Khan SR, Huang P (2006) A Boronic-chalcone derivative exhibits potent anticancer activity through inhibition of the proteasome. Mol Pharmacol 70:426-433
2. Bandgar BP, Gawande SS, Bodade RG, Totre JV, Khobragade CN (2010) Synthesis and biological evaluation of simple methoxylated chalcones as anticancer, anti-inflammatory and antioxidant agents. Bioorg Med Chem 18:1364-1370
3. Belofsky G, Percivill D, Lewis K, Tegos GP, Ekart J (2004) Phenolic metabolic of Dalea versicolor that enhance antibiotic activity against multi-drug resistant bacteria. J Nat Prod 67:481-484
4. Bremner PD, Meyer JJ (1998) Pinocembrin chalcone: an antibacterial compound from Helichrysum trilineatum. Planta Med 64:777
5. Bsasaif SA, Sobahi TR, Khalil AK, Hassan MA (2005) Stereoselective crossed-aldol condensation of hetarylmethyl ketones with aromatic aldehydes in water: synthesis of (2E)-3-Aryl-1-hetarylprop-2-en-1-ones. Bull Korean Chem Soc 26:1677-1681
6. Echeverria C, Santibanez JF, Donoso-Tauda O, Escobar CA, Tagle RR (2009) Structural antitumoral activity relationships of synthetic chalcones. Int J Mol Sci 10:221-231
7. Farrugia LJ (1997) ORTEP-3 for Windows - a version of ORTEP-III with a Graphical User Interface (GUI). J Appl Cryst 30:565
8. Farrugia LJ (1999) WinGX suite for small-molecule single-crystal crystallography. J Appl Cryst 32:837-838
9. Forejtníková H, Lunerová K, Kubínová R, Jankovská D, Marek R, Kares R, Suchý V, Vondrácek J, Machala M (2005) Chemoprotective and toxic potentials of synthetic and natural chalcones and dihydrochalcones in vitro. Toxicology 208:81-93
10. Friss-Möller A, Chen M, Fuursted K, Christensen SB, Kharazmi A (2002) In vitro antimycobacterial and antilegionella activity of licochalcone A from Chinese licorice roots. Planta Med 68:416-419
11. Fukai T, Marumo A, Kaitou K, Kanda T, Terada S, Nomura T (2002) Anti-Helicobacter pylori flavonoids from licorice extract. Life Sci 71:1449-1463
12. Hatano T, Shintani Y, Aga Y, Shiota S, Tsuchiya T, Yoshida T (2000) Phenolic constituents of licorice. viii. Structures of glicophenone and glicoisoflavanone, and effects of licorice phenolics on methicillin-resistant Staphylococcus aureus. Chem Pharm Bull 48:1286-1292
13. Hijova E (2006) Bioavailability of chalcones. Bratisl Lek Listy 107:80-84
14. Ilango K, Valentina P, Saluja G (2010) Synthesis and In vitro anti-cancer activity of some substituted Chalcone derivatives. Res J Pharm Biol Chem Sci 1:354-359
15. Jasinski JP, Butcher RJ, Narayana B, Veena K, Yathirajan HS (2009) (2E)-1-(3-Chlorophenyl)-3-(4-chlorophenyl)prop-2-en-1-one. Acta Cryst E65:2641-2642
16. Joshi AS, Li XC, Nimrod AC, ElSohly HN, Walker LA, Clark AM (2001) Dihydrochalcones from Piper longicaudatum. Planta Med 67:186-188
17. Kaatz GW, Seo SM (1995) Inducible NorA-mediated multidrug resistance in Staphylococcus aureus. Antimicrob Agents Chemother 39:2650-2655
18. Kaatz GW, Seo SM, Ruble CA (1993) Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus. Antimicrob Agents Chemother 37:1086-1094
19. Kaatz GW, Seo SM, Foster T (1999) Introduction of a norA promoter region mutation into the chromosome of a fluoroquinolone-susceptible strain of Staphylococcus aureus using plasmid integration. Antimicrob Agents Chemother 43:2222-2224
20. Kromann H, Larsen M, Boesen T, SchØnning K, Nielsen SF (2004) Synthesis of prenylated benzaldehydes and their use in the synthesis of analogues of licochalcone A. Eur J Med Chem 3:1000-9993
21. Lawrence NJ, Patterson RP, Ooi LL, Cook D, Ducki S (2006) Effects of alpha-substitutions on structure and biological activity of anticancer chalcones. Bioorg Med Chem Lett 16:5844-5848
22. Li DQ (2008) 3-(4-Methoxyphenyl)-1-(2-pyrrolyl)prop-2-en-1-one. Acta Cryst E64:1920
23. Li XZ, Nikaido H (2004) Efflux-mediated drug resistance in bacteria. Drugs 64:159-204
24. Memurry LM, Petrucci REJ, Levy SB (1980) Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli. Proc Natl Acad Sci 77:3974-3977
25. Mustafa K, Kjaergaard HG, Perry NB, Weavers RT (2003) Hydrogen-bonded rotamers of 2′,4′,6′-trihydroxy-3′- formyldihydrochalcone, an intermediate in the synthesis of a dihydrochalcone from Leptospermum recurvum. Tetrahedron 59:6113-6120
26. Nardelli M (1995) PARST95 - an update to PARST: a system of Fortran routines for calculating molecular structure parameters from the results of crystal structure analyses. J Appl Cryst 28:659
27. Neyfakh AA, Borsch CM, Kaatz GW (1993) Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter. Antimicrob Agents Chemother 37:128-129
28. Nielsen SF, Larsen M, Boesen T, SchØnning K, Kromann H (2005) Cationic chalcone antibiotics. Design, synthesis, and mechanism of action. J Med Chem 48:2667-2677
29. Poole KJ (2005) Efflux-mediated antimicrobial resistance. J Antimicrob Chemother 56:20-51
30. Prasad YR, Kumar PR, Ramesh B (2007) Synthesis and antidepressant activity of some new 3-(2′′-hydroxy naphthalen-1′′-yl)- 5-phenyl-2-Isoxazolines. Int J Chem Sci 5:542-548
31. Radwan MAA, Abbas EMH (2009) Synthesis of some pyridine, thiopyrimidine, and isoxazoline derivatives based on the pyrrole moiety. Monatsh Chem 140:229-233
32. Rateb NM, Zohdi HF (2009) Atom-efficient, solvent-free, green synthesis of chalcones by grinding. Synth Commun 39:2789-2794
33. Ravelli RBG, Gigant B, Curmi PA, Jourdain I, Lachkar S, Sobel A (2004) Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain. Nature 428:198
34. Romagnoli R, Baraldi PG, Carrion MD, Cara CL, Cruz-Lopez O, Preti D (2008) Design, synthesis, and biological evaluation of thiophene analogues of chalcones. Bioorg Med Chem 16:5367-5376
35. Sheldrick GM (1997) SHELX97 University of Gottingen, Germany
36. Szliszka E, Czuba ZP, Mazur B, Sedek L, Paradysz A, Krol W (2010) Chalcones enhance TRAIL-induced apoptosis in prostate cancer cells. Int J Mol Sci 11:1-13
37. Tang SP, Kuang DZ, Feng YL, Li W, Chen ZM (2008) 3-[4-(Dimethyl-amino) phenyl]-1-(2-pyrrolyl)prop-2-en-1-one. Acta Cryst E64:1123
38. Tsukiyama RI, Katsura H, Tokuriki N, Kobayashi M (2002) Antibacterial activity of Licochalcone A against spore-forming bacteria. Antimicrob Agents Chemother 46:1226-1230
39. Wong E (1968) The role of chalcones and flavanones in flavonoid biosynthesis. Phytochemistry 7:1751-1758